Urgent.News

What's breaking now, across thousands of outlets.

Culture

Novel siRNA Therapeutic Cuts Liver Fat in MASLD, Early Trial Shows

(MedPage Today) -- One dose of a novel small interfering RNA (siRNA) therapy -- CIDEBsiRNA (also known as ALN-CIDEB) -- led to normal liver fat content and lower alanine aminotransferase (ALT) levels in most patients with metabolic dysfunction...

Novel siRNA Therapeutic Cuts Liver Fat in MASLD, Early Trial Shows

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Culture

More from Tuesday 10 November →